Journal of Hepatology
Volume 47, Issue 2 , Pages 212-219 , August 2007

Muscle GLUT4 in cirrhosis

  • Peter Holland-Fischer

      Affiliations

    • Department of Medicine V (Hepatology and Gastroenterology), Aarhus University Hospital, 44 Noerrebrogade, DK-8000 Aarhus C, Denmark
    • Corresponding Author InformationCorresponding author. Tel.: +45 24212428; fax: +45 89492820.
    • ,
  • Per Heden Andersen

      Affiliations

    • Department of Medicine V (Hepatology and Gastroenterology), Aarhus University Hospital, 44 Noerrebrogade, DK-8000 Aarhus C, Denmark
    • Department of Endocrinology, Ribe County Hospital, Denmark
    • ,
  • Sten Lund

      Affiliations

    • Department of Medical Endocrinology M, Aarhus University Hospital, Denmark
    • ,
  • Steen Bønnelykke Pedersen

      Affiliations

    • Department of Medical Endocrinology C, Aarhus University Hospital, Denmark
    • ,
  • Lars Vinter-Jensen

      Affiliations

    • Department of Medicine V (Hepatology and Gastroenterology), Aarhus University Hospital, 44 Noerrebrogade, DK-8000 Aarhus C, Denmark
    • ,
  • Michael F. Nielsen

      Affiliations

    • Department of Medicine V (Hepatology and Gastroenterology), Aarhus University Hospital, 44 Noerrebrogade, DK-8000 Aarhus C, Denmark
    • ,
  • Andreas Kaal

      Affiliations

    • Department of Medical Endocrinology C, Aarhus University Hospital, Denmark
    • ,
  • Rolf Dall

      Affiliations

    • Department of Anesthesiology, Aarhus University Hospital, Denmark
    • ,
  • Ole Schmitz

      Affiliations

    • Department of Medical Endocrinology M, Aarhus University Hospital, Denmark
    • ,
  • Hendrik Vilstrup

      Affiliations

    • Department of Medicine V (Hepatology and Gastroenterology), Aarhus University Hospital, 44 Noerrebrogade, DK-8000 Aarhus C, Denmark

Received 8 December 2006 ,Revised 6 February 2007 ,Accepted 20 February 2007.

References 

  1. Kasperska-Czyzykowa T, Heding LG, Czyzyk A. Serum levels of true insulin, C-peptide and proinsulin in peripheral blood of patients with cirrhosis. Diabetologia. 1983;25:506–509
  2. Shmueli E, Record CO, Alberti KG. Liver disease, carbohydrate metabolism and diabetes. Baillieres Clin Endocrinol Metab. 1992;6:719–743
  3. Selberg O, Bottcher J, Tusch G, Pichlmayr R, Henkel E, Muller MJ. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology. 1997;25:652–657
  4. Cavallo-Perin P, Cassader M, Bozzo C, Bruno A, Nuccio P, Dall’omo AM, et al. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect. J Clin Invest. 1985;75:1659–1665
  5. Iversen J, Vilstrup H, Tygstrup N. Kinetics of glucose metabolism in relation to insulin concentrations in patients with alcoholic cirrhosis and in healthy persons. Gastroenterology. 1984;87:1138–1143
  6. Petrides AS, DeFronzo RA. Glucose and insulin metabolism in cirrhosis. J Hepatol. 1989;8:107–114
  7. Selberg O, Burchert W, vd HJ, Meyer GJ, Hundeshagen H, Radoch E, et al. Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism. J Clin Invest. 1993;91:1897–1902
  8. Petersen KF, Krssak M, Navarro V, Chandramouli V, Hundal R, Schumann WC, et al. Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis. Am J Physiol. 1999;276:E529–E535
  9. Petrides AS, Groop LC, Riely CA, DeFronzo RA. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis. J Clin Invest. 1991;88:561–570
  10. Cavallo-Perin P, Cassader M, Bozzo C, Bruno A, Nuccio P, Dall’omo AM, et al. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect. J Clin Invest. 1985;75:1659–1665
  11. Nielsen MF, Caumo A, Aagaard NC, Chandramouli V, Schumann WC, Landau BR, et al. Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: Assessment during physiologic glucose and insulin concentrations. Am J Physiol Gastrointest Liver Physiol. 2005;
  12. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 1981;30:1000–1007
  13. Lund S, Holman GD, Zierath JR, Rincon J, Nolte LA, Clark AE, et al. Effect of insulin on GLUT4 cell surface content and turnover rate in human skeletal muscle as measured by the exofacial bis-mannose photolabeling technique. Diabetes. 1997;46:1965–1969
  14. Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, Lowell BB, et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med. 2000;6:924–928
  15. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med. 1999;341:240–246
  16. Ren JM, Marshall BA, Gulve EA, Gao J, Johnson DW, Holloszy JO, et al. Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. J Biol Chem. 1993;268:16113–16115
  17. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005;28:S37–42.
  18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  19. Andersen PH, Lund S, Schmitz O, Junker S, Kahn BB, Pedersen O. Increased insulin-stimulated glucose uptake in athletes: the importance of GLUT4 mRNA, GLUT4 protein and fibre type composition of skeletal muscle. Acta Physiol Scand. 1993;149:393–404
  20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem. 1987;162:156–159
  21. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1980;102:344–352
  22. Buhl ES, Jessen N, Schmitz O, Pedersen SB, Pedersen O, Holman GD, et al. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes. 2001;50:12–17
  23. Lund S, Flyvbjerg A, Holman GD, Larsen FS, Pedersen O, Schmitz O. Comparative effects of IGF-I and insulin on the glucose transporter system in rat muscle. Am J Physiol. 1994;267:E461–E466
  24. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem. 1993;39:578–582
  25. Heding LG. Radioimmunological determination of human C-peptide in serum. Diabetologia. 1975;11:541–548
  26. Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl. 1966;18:118–125
  27. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985;41:810–817
  28. Kruszynska Y, Williams N, Perry M, Home P. The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis. Hepatology. 1988;8:1615–1619
  29. Kruszynska YT, Harry DS, Bergman RN, McIntyre N. Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients. Diabetologia. 1993;36:121–128
  30. Andersen PH, Lund S, Vestergaard H, Junker S, Kahn BB, Pedersen O. Expression of the major insulin regulatable glucose transporter (GLUT4) in skeletal muscle of noninsulin-dependent diabetic patients and healthy subjects before and after insulin infusion. J Clin Endocrinol Metab. 1993;77:27–32
  31. Andersen PH, Vestergaard H, Lund S, Vedel P, Junker S, Kahn BB, et al. The effect of intensive insulin therapy on the insulin-regulatable glucose transporter (GLUT4) expression in skeletal muscle in type 1 diabetes. Diabet Med. 1993;10:699–706
  32. Houmard JA, Weidner MD, Dolan PL, Leggett-Frazier N, Gavigan KE, Hickey MS, et al. Skeletal muscle GLUT4 protein concentration and aging in humans. Diabetes. 1995;44:555–560
  33. Garvey WT, Maianu L, Hancock JA, Golichowski AM, Baron A. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes. 1992;41:465–475
  34. Pedersen O, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, et al. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes. 1990;39:865–870
  35. Dela F, Ploug T, Handberg A, Petersen LN, Larsen JJ, Mikines KJ, et al. Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes. 1994;43:862–865
  36. Kraniou GN, Cameron-Smith D, Hargreaves M. Effect of short-term training on GLUT-4 mRNA and protein expression in human skeletal muscle. Exp Physiol. 2004;89:559–563
  37. Kraniou Y, Cameron-Smith D, Misso M, Collier G, Hargreaves M. Effects of exercise on GLUT-4 and glycogenin gene expression in human skeletal muscle. J Appl Physiol. 2000;88:794–796
  38. O’Brien RM, Granner DK. Regulation of gene expression by insulin. Physiol Rev. 1996;76:1109–1161
  39. Flores-Riveros JR, McLenithan JC, Ezaki O, Lane MD. Insulin down-regulates expression of the insulin-responsive glucose transporter (GLUT4) gene: effects on transcription and mRNA turnover. Proc Natl Acad Sci USA. 1993;90:512–516
  40. Jessen N, Buhl ES, Schmitz O, Lund S. Impaired insulin action despite upregulation of proximal insulin signaling: Novel insights into skeletal muscle insulin resistance in liver cirrhosis. J Hepatol. 2006;45:797–804
  41. Merli M, Leonetti F, Riggio O, Valeriano V, Ribaudo MC, Strati F, et al. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology. 1999;30:649–654
  42. Petrides AS, Stanley T, Matthews DE, Vogt C, Bush AJ, Lambeth H. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity. Hepatology. 1998;28:141–149
  43. Shmueli E, Orskov H, Alberti KG, Record CO. Octreotide treatment does not improve impaired glucose uptake in cirrhosis. Horm Metab Res. 1993;25:317–320
  44. Ryder JW, Yang J, Galuska D, Rincon J, Bjornholm M, Krook A, et al. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes. 2000;49:647–654

PII: S0168-8278(07)00127-4

doi: 10.1016/j.jhep.2007.02.012

Journal of Hepatology
Volume 47, Issue 2 , Pages 212-219 , August 2007

Article Tools

* Image Usage & Resolution